<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04107883</url>
  </required_header>
  <id_info>
    <org_study_id>LX-2019-LT-1</org_study_id>
    <nct_id>NCT04107883</nct_id>
  </id_info>
  <brief_title>Effect of Transfusion of Plasma on Endothelial During Liver Transplantation</brief_title>
  <official_title>Comparison of the Effect of Different Strategies of Plasma Management During Orthotopic Liver Transplantation on Endothelial Condition and Short-term Outcome in Patients With End-Stage Liver Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Chao Yang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Chao Yang Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the effects on endothelial condition and short-term outcome in different strategies
      of plasma transfusion during liver transplantation in patients with end-stage liver disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>syndecan-1</measure>
    <time_frame>5 days</time_frame>
    <description>plasma concentration of syndecan-1</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>survival</measure>
    <time_frame>30 days</time_frame>
    <description>survival during 30 days after operation</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>End Stage Liver DIsease</condition>
  <condition>Liver Transplantation</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Do not perform plasma transfusion during operation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>anhapetic group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Perform plasma transfusion during anhapetic phase.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>neohepatic group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Perform plasma transfusion during neohepatic phase.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>fresh frozen plasma</intervention_name>
    <description>perform plasma transfusion in different phases during perioperation</description>
    <arm_group_label>anhapetic group</arm_group_label>
    <arm_group_label>neohepatic group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>blood sample</intervention_name>
    <description>get blood samples at several specific points in time during perioperation</description>
    <arm_group_label>anhapetic group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>neohepatic group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Child B/C cirrhosis

          -  patients who undergo the first OLT

        Exclusion Criteria:

          -  re-transplant

          -  combined liver-kidney transplantation

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anshi Wu</last_name>
    <role>Study Chair</role>
    <affiliation>Capital Medical University Affiliated Beijing Chaoyang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xun Liu</last_name>
    <phone>+86 13466505725</phone>
    <email>13466505725@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anshi Wu</last_name>
    <phone>+86 010 85231330</phone>
    <email>wuanshi@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Capital Medical University Affiliated Beijing Chaoyang Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liu Xun</last_name>
      <phone>13466505725</phone>
      <phone_ext>+86</phone_ext>
      <email>13466505725@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Wu A Shi</last_name>
      <phone>85231330</phone>
      <phone_ext>+86 010</phone_ext>
      <email>wuanshi@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 20, 2019</study_first_submitted>
  <study_first_submitted_qc>September 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2019</study_first_posted>
  <last_update_submitted>January 22, 2020</last_update_submitted>
  <last_update_submitted_qc>January 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Chao Yang Hospital</investigator_affiliation>
    <investigator_full_name>Xun Liu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>endothelial</keyword>
  <keyword>plasma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>End Stage Liver Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

